NCT07250178

Brief Summary

Patients undergoing conventional total laparoscopic hysterectomy (TLH) are typically placed in the Trendelenburg position with intraabdominal carbon dioxide (CO₂) insufflation. These factors may contribute to intraoperative complications such as lymphedema, impaired pulmonary function, and increased intracranial pressure. Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES), a novel minimally invasive technique, provides retroperitoneal or transperitoneal access through the vaginal route and offers the potential for shorter operative times and lower intraabdominal pressure requirements. This study aims to evaluate whether the vNOTES technique can reduce intraoperative and postoperative complications compared with TLH. Particular attention will be given to hemodynamic parameters and changes in optic nerve sheath diameter as an indirect indicator of intracranial pressure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 18, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 26, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

November 27, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2026

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 5, 2026

Completed
Last Updated

January 7, 2026

Status Verified

January 1, 2026

Enrollment Period

1 month

First QC Date

November 18, 2025

Last Update Submit

January 5, 2026

Conditions

Keywords

Laparoscopic HysterectomyvNOTESOptic Nerve Sheath DiameterIntracranial Pressure

Outcome Measures

Primary Outcomes (1)

  • Optic nerve sheath diameter (ONSD) measured

    All measurements were performed using a high-resolution ultrasound device equipped with a 7-13 MHz linear probe. The ultrasound gain and depth settings were standardized for all patients (depth: 4-5 cm; focus: at the level of the optic disc). Patient Position: Measurements were obtained with patients in the supine position. The eyes were kept closed, and sterile ultrasound gel was applied without exerting pressure on the globe. The probe was gently placed on the upper eyelid, and measurements were taken in the transverse plane. The optic nerve sheath diameter was measured 3 mm distal to the optic disc, from outer edge to outer edge (outer-to-outer).

    From baseline (before induction) to 10, 30, 60, and 90 minutes after Trendelenburg and CO₂ insufflation, and 10 minutes after desufflation.

Secondary Outcomes (9)

  • Blood pressure measurement

    It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.

  • Measurement of heart rate

    It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.

  • intraabdominal pressure

    It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.

  • end-tidal CO₂ (EtCO₂)

    It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.

  • peak airway pressure

    It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.

  • +4 more secondary outcomes

Study Arms (2)

vNOTES Hysterectomy for Assessment of Intraoperative Optic Nerve Sheath Diameter

EXPERIMENTAL

Vajinal natural orifice transluminal endoscopic surgery (vNOTES): In the vNOTES group, the surgery was performed using a transvaginal approach with a self-retaining vaginal port. Following colpotomy, CO₂ insufflation was applied through the vaginal port, ensuring intra-abdominal pressure did not exceed 15 mmHg. The procedure involved occlusion and ligation of the uterine artery under direct endoscopic visualization, followed by sampling through the vaginal route. Pneumoperitoneum was released before closing the vaginal vault. The uterus was then removed through the vaginal route.

Procedure: vNOTES

Total Laparoscopic Hysterectomy for Assessment of Intraoperative Optic Nerve Sheath Diameter

ACTIVE COMPARATOR

Total laparoscopic hysterectomy (TLH): In the TLH group, the surgical procedure was performed under standard laparoscopic conditions using a 10 mm umbilical camera port and two 5 mm accessory trocars. CO₂ insufflation was initiated to maintain intra-abdominal pressure below 15 mmHg. The uterus is dissected using a bipolar vessel sealing device, and the specimen is removed transvaginally. The vaginal cuff and abdominal trocar entries are sutured laparoscopically under direct visualization.

Procedure: TLH

Interventions

vNOTESPROCEDURE

vNOTES: In the vNOTES group, the surgery was performed using a transvaginal approach with a self-retaining vaginal port. Following colpotomy, CO₂ insufflation was applied through the vaginal port, ensuring intra-abdominal pressure did not exceed 15 mmHg. The procedure involved occlusion and ligation of the uterine artery under direct endoscopic visualization, followed by sampling through the vaginal route. Pneumoperitoneum was released before closing the vaginal vault. The uterus was then removed through the vaginal route.

vNOTES Hysterectomy for Assessment of Intraoperative Optic Nerve Sheath Diameter
TLHPROCEDURE

In the TLH group, the surgical procedure was performed under standard laparoscopic conditions using a 10 mm umbilical camera port and two 5 mm accessory trocars. CO₂ insufflation was initiated to maintain intra-abdominal pressure below 15 mmHg. The uterus is dissected using a bipolar vessel sealing device, and the specimen is removed transvaginally. The vaginal cuff and abdominal trocar entries are sutured laparoscopically under direct visualization.

Total Laparoscopic Hysterectomy for Assessment of Intraoperative Optic Nerve Sheath Diameter

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female patients are eligible for inclusion, as the surgical procedures under investigation (vNOTES and total laparoscopic hysterectomy) are applicable solely to women undergoing gynecologic surgery.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • voluntary participation,
  • elective laparoscopic hysterectomy scheduled by gynecology-oncology specialists,
  • ASA physical status I-II

You may not qualify if:

  • included unwillingness to participate,
  • emergency surgery,
  • age \<18 years,
  • prior major pelvic or abdominal surgery,
  • ASA ≥III,
  • Chronic pulmonary disease, pulmonary hypertension, glaucoma, diabetic retinopathy, intracranial pathology (mass, hydrocephalus, optic neuritis), prior ocular or intracranial surgery, cardiac failure (EF \<40%), active infection, or systemic inflammatory diseases other than malignancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Diyarbakır, Outside of the US, 21070, Turkey (Türkiye)

Location

Related Publications (1)

  • Guloglu H, Cetinkaya D, Oge T, Bilir A. Evaluation of the effect of trendelenburg position duration on intracranial pressure in laparoscopic hysterectomies using ultrasonographic optic nerve sheath diameter measurements. BMC Anesthesiol. 2024 Jul 15;24(1):238. doi: 10.1186/s12871-024-02624-4.

    PMID: 39010013BACKGROUND

MeSH Terms

Conditions

Endometrial NeoplasmsMetrorrhagiaMyofibroma

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesUterine HemorrhageHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsNeoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Fatma Acil, M.D.

    Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the nature of the surgical interventions, blinding is not feasible. Both surgeons and outcome assessors are aware of group allocation. Participants may also recognize their assigned intervention based on the operative approach.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a single-center, prospective, randomized controlled trial with a parallel assignment design. Eligible patients undergoing elective laparoscopic hysterectomy will be randomly allocated in a 1:1 ratio to either the vNOTES group or the TLH group. Randomization will be performed using a computer-generated sequence, and allocation concealment will be maintained with sealed opaque envelopes. Each participant will receive only one surgical intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 18, 2025

First Posted

November 26, 2025

Study Start

November 27, 2025

Primary Completion

January 2, 2026

Study Completion

January 5, 2026

Last Updated

January 7, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD), including baseline demographic variables and primary/secondary outcome measures, will be shared.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
study completion + 6 months
Access Criteria
Researchers may request access to the de-identified IPD by contacting the principal investigator at:\[acilfatma@gmail.com\]. Requests will be evaluated by the investigators, and data will be shared after approval and completion of a data-sharing agreement."

Locations